skip to primary navigationskip to content

Dr Emanuele Di Angelantonio

Dr Emanuele Di Angelantonio

Reader in Translational Epidemiology

Academic Director MPhil in Public Health

Research themes

Population Sciences:

Research Interests

Cardiovascular Epidemiology

My research focuses on issues related to screening and risk assessment for cardiovascular disease with a particular interest on biochemical and genetic factors. I work closely with several large-scale epidemiological studies, including:

  • Emerging Risk Factors Collaboration (a collaborative meta-analysis of individual data from several prospective studies);
  • Reykjavik Prospective Study (a large prospective study of middle-aged men and women in Iceland)
  • Pakistan Risk of Myocardial Infarction Study (a case-control study of gene-lifestyle interplay in myocardial infarction in Pakistan).

I am also the scientific coordinator of the Natriuretic Peptides Studies Collaboration (a collaborative pooling of individual participant data on natriuretic peptides and cardiovascular disease) and involved in planning epidemiological studies of cardiovascular disease in previously understudied populations.


cardiovascular epidemiology ; epidemiology

Key Publications

Left ventricular mass and the risk of sudden cardiac death: a population-based study. Laukkanen JA, Khan H, Kurl S, Willeit P, Karppi J, Ronkainen K, Di Angelantonio E. J Am Heart Assoc. 2014 Nov 5;3(6).

Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke. Thaler DE, Ruthazer R, Weimar C, Serena J, Mattle HP, Nedeltchev K, Mono ML, Di Angelantonio E, Elkind MS, Di Tullio MR, Homma S, Michel P, Meier B, Furlan AJ, Lutz JS, Kent DM. Neurology. 2014 Oct 22.

Autologous pericardium annuloplasty: a "physiological" mitral valve repair. Salvador L, Cavarretta E, Minniti G, Di Angelantonio E, Salandin V, Frati G, Polesel E, Valfrè C. J Cardiovasc Surg (Torino). 2014 Dec;55(6):831-9.

The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, Mehenny S, Mant J, Di Angelantonio E, Thompson SG, Ouwehand W, Roberts DJ, Danesh J. Trials. 2014 Sep 17;15:363.

Metabolic mediators of body-mass index and cardiovascular risk. Wormser D, Wood AM, Di Angelantonio E, Thompson SG, Danesh J; Emerging Risk Factors Collaboration. Lancet. 2014 Jun 14;383(9934):2042-3.

Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Thaler DE, Ruthazer R, Weimar C, Mas JL, Serena J, Di Angelantonio E, Papetti F, Homma S, Mattle HP, Nedeltchev K, Mono ML, Jaigobin C, Michel P, Elkind MS, Di Tullio MR, Lutz JS, Griffith J, Kent DM. Neurology. 2014 Jul 15;83(3):221-6.

Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E. Ann Intern Med. 2014 Mar 18;160(6):398-406.

Glycated hemoglobin measurement and prediction of cardiovascular disease. Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njølstad I, Nissinen A, Brunner EJ, Kuller LH, Price JF, Sundström J, Knuiman MW, Feskens EJ, Verschuren WM, Wald N, Bakker SJ, Whincup PH, Ford I, Goldbourt U, Gómez-de-la-Cámara A, Gallacher J, Simons LA, Rosengren A, Sutherland SE, Björkelund C, Blazer DG, Wassertheil-Smoller S, Onat A, Marín Ibañez A, Casiglia E, Jukema JW, Simpson LM, Giampaoli S, Nordestgaard BG, Selmer R, Wennberg P, Kauhanen J, Salonen JT, Dankner R, Barrett-Connor E, Kavousi M, Gudnason V, Evans D, Wallace RB, Cushman M, D'Agostino RB Sr, Umans JG, Kiyohara Y, Nakagawa H, Sato S, Gillum RF, Folsom AR, van der Schouw YT, Moons KG, Griffin SJ, Sattar N, Wareham NJ, Selvin E, Thompson SG, Danesh J. JAMA. 2014 Mar 26;311(12):1225-33.

Please see Pubmed for full list of publications.

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.